A University of Michigan-led study found that the fat tissue in bone marrow is a significant source of the hormone adiponectin, which helps maintain insulin sensitivity, break down fat, and has been linked to decreased risk of cardiovascular disease, diabetes, and obesity-associated cancers.
Bone marrow adipose tissue has primarily been associated with negative health effects, most notably because of a documented relationship to reduced bone mass and increased risks of fractures and osteoporosis.
The new study - which included people with anorexia, patients undergoing chemotherapy, rabbits and mice - suggests that this type of fat may also have benefits.
Researchers have long studied the function of our fat, or 'adipose' tissue, in hopes of better understanding the link between obesity and ill health.
More From This Section
One possible link is adiponectin, a hormone produced by adipose tissue that helps preserve insulin action. High levels of adiponectin are linked to decreased risk of diabetes and cardiovascular disease.
An outstanding question in the field has been why adiponectin, which is produced by adipose tissue, increases as people lose body fat.
Previous research has focused on peripheral white adipose tissue, which has been believed to be the sole source of adiponectin.
The new study found however that bone marrow fat tissue - which increases as body weight falls - is a previously unrecognised source of adiponectin during calorie restriction.
The study found that both marrow adipose tissue and adiponectin increased in humans with anorexia, and in patients undergoing chemotherapy or radiation treatment for ovarian or endometrial cancer.
The findings appear in the journal Cell Metabolism.